Repopulation of EGFP-Transduced UCB Subsets in NOD/SCID Mice and CAFC Assay
Vector/Packaging Cell Line . | UCB Subset . | Transduction Efficiency % EGFP . | EGFP+/Chimeric Mice3-150 . | Chimerism in NOD/SCID % CD45 . | EGFP+ on CD45+ Cells % . | CAFC wk 6 % EGFP . |
---|---|---|---|---|---|---|
MFG-EGFP/Am12 | CD34+ | 313-151 (29-51) | 6/10 | 12 (2-65) | 2 (0-18) | 6 (0-11) |
SF-EGFP/PG13 | CD34+ | 663-151 | 4/4 | 8 (3-12) | 23 (2-41) | 27 (26-27) |
P value | — | — | >.05 | .032 | .12 | |
MFG-EGFP/Am12 | CD34+CD38− | 53-151 | 0/4 | 5 (1-24) | 0 | ND |
SF-EGFP/PG13 | CD34+CD38− | 213-151 | 1/3 | 6 (4-9) | 3 | 253-151 |
P value | — | — | >.05 | >.05 | — |
Vector/Packaging Cell Line . | UCB Subset . | Transduction Efficiency % EGFP . | EGFP+/Chimeric Mice3-150 . | Chimerism in NOD/SCID % CD45 . | EGFP+ on CD45+ Cells % . | CAFC wk 6 % EGFP . |
---|---|---|---|---|---|---|
MFG-EGFP/Am12 | CD34+ | 313-151 (29-51) | 6/10 | 12 (2-65) | 2 (0-18) | 6 (0-11) |
SF-EGFP/PG13 | CD34+ | 663-151 | 4/4 | 8 (3-12) | 23 (2-41) | 27 (26-27) |
P value | — | — | >.05 | .032 | .12 | |
MFG-EGFP/Am12 | CD34+CD38− | 53-151 | 0/4 | 5 (1-24) | 0 | ND |
SF-EGFP/PG13 | CD34+CD38− | 213-151 | 1/3 | 6 (4-9) | 3 | 253-151 |
P value | — | — | >.05 | >.05 | — |